Long-Term Follow-Up May be Useful in Coronavirus Disease 2019 Survivors to Prevent Chronic Complications

참고문헌 (10)

1. Zhou F, "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China : a retrospective cohort study", Lancet, 395, pp.1054~1062 (2020)
2. Gattinoni L, "COVID-19 pneumonia: different respiratory treatments for different phenotypes?", Intensive Care Med, 46, pp.1099~1102 (2020)
3. Yao XH, "A pathological report of three COVID-19 cases by minimally invasive autopsies", Zhonghua Bing Li Xue Za Zhi, 49, pp.411~417 (2020)
4. Huang C, "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China", Lancet, 395, pp.497~506 (2020)
5. Ackermann M, "Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19", N Engl J Med, 383, pp.120~128 (2020)
6. Brown KK, "The natural history of progressive fibrosing interstitial lung diseases", Eur Respir J, 55, pp.2000085~ (2020)
7. Aliberti S, "Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases", BMC Pulm Med, 14, pp.194~ (2014)
8. Hsu HH, "Correlation of high-resolution CT, symptoms, and pulmonary function in patients during recovery from severe acute respiratory syndrome", Chest, 126, pp.149~158 (2004)
9. Venkataraman T, "The role of epidermal growth factor receptor(EGFR)signaling in SARS coronavirus-induced pulmonary fibrosis", Antiviral Res, 143, pp.142~150 (2017)
10. Demelo-Rodríguez P, "Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels", Thromb Res, 192, pp.23~26 (2020)

관련 논문AI추천